tiprankstipranks
Vivesto AB ADR (OASMY)
OTHER OTC:OASMY
US Market
Holding OASMY?
Track your performance easily

Vivesto AB ADR (OASMY) Stock Price & Analysis

49 Followers

OASMY Stock Chart & Stats


Financials

Annual

Ownership Overview

0.02%99.98%
Insiders
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

OASMY FAQ

What was Vivesto AB ADR’s price range in the past 12 months?
Vivesto AB ADR lowest stock price was $0.02 and its highest was $0.06 in the past 12 months.
    What is Vivesto AB ADR’s market cap?
    Currently, no data Available
    When is Vivesto AB ADR’s upcoming earnings report date?
    Vivesto AB ADR’s upcoming earnings report date is Feb 20, 2025 which is in 88 days.
      How were Vivesto AB ADR’s earnings last quarter?
      Currently, no data Available
      Is Vivesto AB ADR overvalued?
      According to Wall Street analysts Vivesto AB ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Vivesto AB ADR pay dividends?
        Vivesto AB ADR pays a Notavailable dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on Vivesto AB ADR dividends here
          What is Vivesto AB ADR’s EPS estimate?
          Vivesto AB ADR’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Vivesto AB ADR have?
          Vivesto AB ADR has 179,347,820 shares outstanding.
            What happened to Vivesto AB ADR’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Vivesto AB ADR?
            Currently, no hedge funds are holding shares in OASMY
            ---

            Vivesto AB ADR Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            -12.28%
            12-Months-Change

            Fundamentals

            Return on Equity
            -43.60%
            Trailing 12-Months
            Asset Growth
            -34.33%
            Trailing 12-Months

            Company Description

            Vivesto AB ADR

            Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            CytoDyn
            Northwest Biotherapeutics
            Advaxis
            Ibio
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis